参脉注射液治疗心源性休克的临床观察

Study of Shenmai injection on cardiogenic shock

目的 观察参脉注射液治疗心源性休克的临床疗效。方法 在常规治疗的基础上 ,治疗组静脉点滴参脉注射液 ;对照组静脉点滴多巴胺。结果 治疗组总有效率为 90 .0 % ,对照组总有效率 81.8% ,组间比较无显著性差异 (P >0 .0 5)。结论 参脉注射液具有升高血压扩张冠脉双重作用 。

Objective To study the effect of Shenmai injection on cardiogenic shock. Methods 52 patients with cardiogenic shock were randomly allocated to two groups. In treatment group (n=30) Shenmai injection was utilized and in controlgroup (n=22) dopamine injection were carried on under routine medicine. Results There was not significant difference between the remarkable effective rate in treatment group (90.0%) and control group (81.8%,P>0.05). Conclusions The two therapies can both increase blood pressure obviously, But SMI can also extend coronary artery, improve microcirculation and reduce oxygen consumption of cardiac cell. Clinical study showed that this extra function make SMI therapy more effective in treatment of cardiogenic shock.